Deutsch
English
Русский

Universitätsklinikum Würzburg 

ZIM (Zentrum Innere Medizin)
Haus A3/A4 

Oberdürrbacherstr. 6

97080 Würzburg

ZOM / ZIM

L-PK: LPK als Biomarker für Lebererkrankungen

BRIVANIB: A Randomized, Double-blind, Multi-center Phase III Study of Brivanib plus Best Supportive Care (BSC) versus Placebo plus BSC in Subjects with Advanced Hepatocellular Carcinoma (HCC) who have Failed or are Intolerant to Sorafenib: The BRISK PS Study (Clinical Protocol CA182034)

HCC Bridge Study: Bridge to Better Outcomes in Hepatocellular Carcinoma (Protocol CA182023)

FLU002: An International Observational Study to Characterize Adults with Influenza A – Pandemic H1N1 (H1N1v), INSIGHT H1N1v Outpatient Study (FLU 002)

FLU003: An International Observational Study to Characterize Adults Who Are Hospitalized with Complications of Influenza A –Pandemic H1N1 (H1N1v), INSIGHT H1N1v Hospitalization Study (FLU 003)